Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

Paratek Pharmaceuticals soars after revealing it is to appear at five investor conferences

Two biotechs - Paratek and Intra-Cellular - were the stocks to have on Wednesday morning.


Paratek Pharmaceuticals Inc (NASDAQ:PRTK), up 32% at US$25.075

The tetracycline chemistry specialist surged as it revealed it would participate in five upcoming investor conferences.

Intra-Cellular Therapies Inc (NASDAQ:ITCI), up 32% at US$14.82.

The shares were wanted after the biotech announced a positive regulatory update on its schizophrenia program.

The US Food and Drug Administration (FDA) had been concerned that its candidate, lumateperone, had shown worrying signs of toxicity when used in tests on animals, but has been convinced that humans are different to other animals.


Precipio Inc (NASDAQ:PRPO), down 47% at US$2.35.

The biotech's shares slumped as it announced plans to raise US$6mln through an underwritten stock offering. The units being offered include convertible preferred stock that can be converted into Precipio common stock at US$2.50 a pop.

23 Aug 2017


0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies